CAS RN: 102130-43-8

ATRACTYLOSIDE POTASSIUM SALT

Product Availability

Choose a grade to view its available package options.

11 package records10 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260617 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250527 100mg In stock Shanghai Inquiry
Batchno.20260106 250mg In stock Shanghai Inquiry
Batchno.20251030 25mg In stock Shanghai Inquiry
Batchno.20251106 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251003 100mg Out of stock Inquiry
Batchno.20250731 10mg In stock Inquiry
Batchno.20260511 1mg In stock Inquiry
Batchno.20250310 25mg In stock Inquiry
Batchno.20260205 50mg In stock Inquiry
Batchno.20250326 5mg In stock Inquiry
  • Product code: starshine_CAS102130-43-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

102130-43-8 / dipotassium;[(2S,3R,4R,5R,6R)-2-[[(1R,4R,5R,7R,9R,10S,13R,15S)-5-carboxy-15-hydroxy-9-methyl-14-methylidene-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)-3-(3-methylbutanoyloxy)-5-sulfonatooxyoxan-4-yl] sulfate

Atractyloside potassium salt | RefChem:560329 | 634-446-8

Standard CAS: 102130-43-8 Multi CAS: Yes

Basic Information

CAS
102130-43-8
Multi CAS
Yes
Molecular Formula
C30H44K2O16S2
Molecular Weight
803.000000
Exact Mass
802.134491
SMILES
CC(C)CC(=O)O[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O[C@@H]2C[C@H]([C@H]3CC[C@@]45C[C@@H](CC[C@H]4[C@@]3(C2)C)C(=C)[C@@H]5O)C(=O)O)CO)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[K+].[K+]
InChI
InChI=1S/C30H46O16S2.2K/c1-14(2)9-22(32)44-25-24(46-48(39,40)41)23(45-47(36,37)38)20(13-31)43-28(25)42-17-10-18(27(34)35)19-7-8-30-11-16(15(3)26(30)33)5-6-21(30)29(19,4)12-17;;/h14,16-21,23-26,28,31,33H,3,5-13H2,1-2,4H3,(H,34,35)(H,36,37,38)(H,39,40,41);;/q;2*+1/p-2/t16-,17+,18+,19+,20+,21-,23+,24-,25+,26-,28-,29+,30+;;/m0../s1
InChIKey
IUCNQFHEWLYECJ-DRMNZGOTSA-L
Synonyms
Atractyloside potassium salt RefChem:560329 634-446-8 CHEMBL2028191

Computed Properties

Structural Parameters

Heavy atom count
50
Fraction Csp3
0.87
Rotatable bonds
11
H-bond acceptors
15
H-bond donors
3
Molar refractivity
158.7
TPSA
255.38

LogP / Solubility

WLOGP
-5.01
MLOGP
-4.34
XLogP3
-5.01
Consensus LogP
-4.79
Log S (ESOL)
-0.94
Class (ESOL)
Very soluble
Log S (Ali)
-2.53
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.04
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-11.18

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Safety & Transport

Pictogram(s)
Acute Toxic
Signal
Danger
GHS Hazard Statements
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal] H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]
Precautionary Statement Codes
P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501

Get In Touch

Contact Us